James is Commercial Director of DATA-CAN, working to increase patient-approved access and analysis of UK cancer data. His expertise is in cancer, genetics, data, precision medicine and starting new ventures. He was previously a consultant at McKinsey, director at Cancer Research UK, partner at the evergreen life science venture fund Syncona, managing director at Genomics England, and COO of the Precision Medicine Catapult.
AI has become an incredibly important diagnostic tool in the fight against one of the world’s biggest killers: cancer. With 10 million people around the world losing their lives to cancer...